Fred Alger Management Adds Over 1.5 Million Shares of NTRA to Portfolio

According to a recent Form 13F filing submitted to the SEC, Fred Alger Management, LLC disclosed a noteworthy and bullish position in NTRA stock. Here’s what you need to know about Natera, Inc., as well as Fred Alger Management’s position in shares of NTRA stock:

About Natera, Inc. (NASDAQ: NTRA)

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual’s tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas. Learn more about Natera, Inc. on their website here

Fred Alger Management’s Position in NTRA Stock

According to the most recent 13F filed by Fred Alger Management, the firm added 1,534,001 shares of NTRA stock to it holdings in the recent quarter. That brings their total long position in Natera, Inc. to 8,781,346 shares, representing approximately 8.9970% of the entire 97,602,896 NTRA shares outstanding. Based on the most recent closing price of $34.17 per share of NTRA, the entire Fred Alger Management position in Natera, Inc. stock is worth roughly $300,058,592.82.

Summary

Be sure to check out more recent 13F filings here to stay up to date on the latest disclosures from institutional investment managers like Fred Alger Management. Also be sure to check out more recent 13F filing analysis news here.